From: A preliminary study: MUC5B promoter polymorphism and its association with IPF
 | IPF patients (group I) (n = 42) | Other ILD patients (group II) (n = 47) | Control subjects (group III) (n = 40) | P value | Pairs |
---|---|---|---|---|---|
Genotype | Â | Â | Â | Â | Â |
TT | 5 (11.9%) | 2 (4.3%) | 2 (5%) | 0.003 | 1*2 = 0.043 |
GT | 21 (50%) | 15 (31.9%) | 6 (15%) | Â | 1*3 = 0.001 |
GG | 16 (38.1%) | 30 (63.8%) | 32 (80%) | Â | 2*3 = 0.184 |
Genotype | Â | Â | Â | Â | 1*2 = 0.015 |
TT or GT | 26 (61.9%) | 17 (36.2%) | 8 (20%) | < 0.001 | 1*3 < 0.001 |
GG | 16 (38.1%) | 30 (63.8%) | 32 (80%) | Â | 2*3 = 0.097 |